| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/09/2009 | US20090176789 Diazaspirodecane orexin receptor antagonists |
| 07/09/2009 | US20090176788 Imidazo[1,2-B]Pyridazines, Processes, Uses, Intermediates and Compositions |
| 07/09/2009 | US20090176782 Inhibitors of tace |
| 07/09/2009 | US20090176777 Imidazo (1,2-a)Pyridin-3-YL-Acetic Acid Hydrazides, Proesses for Their Preparation and Pharmaceutical Uses Thereof |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176770 e.g. 1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl 4-(2-oxo-1,2,4.5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; analgesic, antidiabetic agent; migraine or cluster headaches, non-insulin-dependent diabetes |
| 07/09/2009 | US20090176769 Cgrp receptor antagonists |
| 07/09/2009 | US20090176763 Azaindoles useful as inhibitors of JAK and other protein kinases |
| 07/09/2009 | US20090176756 Substituted thiazoles and their use for producing drugs |
| 07/09/2009 | US20090176739 Optical isomers of an iloperidone metabolite |
| 07/09/2009 | US20090176736 Pharmaceutical composition for conformational diseases |
| 07/09/2009 | US20090176728 Treatment of CNS Conditions |
| 07/09/2009 | US20090176715 Pharmaceutical Compositions and Methods Utilizing a D-Amino Acid |
| 07/09/2009 | US20090176711 Inhibitors of amyloid precursor protein processing |
| 07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090175968 Dietary compositions for promoting brain health |
| 07/09/2009 | US20090175965 Antiscarring, antiaging, photodamaged skin or as a depilatory; unsaponifiable component from canola oil, rapeseed oil, sunflower oil, palm oil, maize oil, sesame oil, wheatgerm oil and one from avocado oil, lupin oil, or soybean oil |
| 07/09/2009 | US20090175935 Pharmaceutical compositions of duloxetine |
| 07/09/2009 | US20090175934 Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same |
| 07/09/2009 | US20090175891 Preventive And Therapeutic Vaccine For Huntington's Disease |
| 07/09/2009 | US20090175853 Method for treating amyloid disease |
| 07/09/2009 | US20090175850 NOGO Receptor Homologs |
| 07/09/2009 | US20090175847 Humanized antibodies to ab (20-42) globulomer and uses thereof |
| 07/09/2009 | US20090175835 Composition for treating damage of central or peripheral nerve system |
| 07/09/2009 | US20090175823 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 07/09/2009 | DE60019555C5 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit 2-oxy-benzoxazinonderivate for treatment of obesity |
| 07/09/2009 | CA2812705A1 Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2747008A1 Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2747000A1 Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2710946A1 Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 07/09/2009 | CA2710903A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/09/2009 | CA2710743A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use |
| 07/09/2009 | CA2710477A1 Tetrasubstituted benzenes |
| 07/09/2009 | CA2710318A1 Drugs as well as their production and use in the treatment of pain-associated neuropathies |
| 07/09/2009 | CA2709961A1 Benzothiazole and benzoxazole derivatives and methods of use |
| 07/09/2009 | CA2709676A1 Thiazolylidine urea and amide derivatives and methods of use thereof |
| 07/09/2009 | CA2709524A1 Combination between an isothiocyanate and levodopa for parkinson's disease treatment |
| 07/09/2009 | CA2709354A1 Anti-amyloid antibodies and uses thereof |
| 07/08/2009 | EP2077278A1 Peptide derived from neurotensin receptor 3 and use in the treatment of psychiatric disorders |
| 07/08/2009 | EP2077111A1 Antidepressant agent |
| 07/08/2009 | EP2077110A1 Glutamine-containing composition for increasing blood flow |
| 07/08/2009 | EP2076515A1 Thiophene pyrazolopyrimidine compounds |
| 07/08/2009 | EP2076514A1 Spiro (furo ý3, 2-c¨pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
| 07/08/2009 | EP2076508A2 Biaryl ether urea compounds |
| 07/08/2009 | EP2076506A2 Heterocyclic-substituted piperidines as orl-1 ligands |
| 07/08/2009 | EP2076502A2 Substituted carboxamides as group i metabotropic receptor antagonists |
| 07/08/2009 | EP2076497A1 Aminomethyl-4-imidazoles |
| 07/08/2009 | EP2076496A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 07/08/2009 | EP2076489A1 Arylsulfonamidyl tetralin derivatives and uses thereof |
| 07/08/2009 | EP2076262A1 Ih channel inhibitors for the promotion of wakefulness |
| 07/08/2009 | EP2076258A2 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
| 07/08/2009 | EP2076253A2 Use of chlorine guanabenz derivatives for treating prion-based diseases |
| 07/08/2009 | EP2076239A1 Combination therapy |
| 07/08/2009 | EP1948661B1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/08/2009 | EP1869038B1 Substituted 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridin-2-ylamine compounds and their use for producing drugs |
| 07/08/2009 | EP1843767B1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders. |
| 07/08/2009 | EP1740202A4 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1511740B1 Phenyl-thiophene type vitamin d receptor modulators |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
| 07/08/2009 | EP1401808B1 Gpe analogs and peptidomimetics |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1126826B9 Multiparticulate modified release composition of methylphenidate |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100509804C N-substituted piperidine derivatives as serotonin receptor agents |
| 07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |
| 07/08/2009 | CN100509791C Compound and use of the compound as glycine transport inhibitors |
| 07/08/2009 | CN100509789C Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 07/08/2009 | CN100509788C Neurotensin active 2,3-diaryl-pyrazolidine derivatives |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509758C Crystal of triterpene derivative |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/08/2009 | CN100509046C Beta-cyclodextrin and polyoxyethylenated castor oil for preparing injection liquid for restoring conscious ness and preparing method thereof |
| 07/08/2009 | CN100509020C Plaster for bone disease |
| 07/08/2009 | CN100509008C Shutongfang for killing pain and preparation and use thereof |
| 07/08/2009 | CN100508980C Compositions for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508975C Use of pyrazolopyridine compound |
| 07/08/2009 | CN100508974C Transdermal patch for administering fentanyl |
| 07/08/2009 | CN100508966C Pharmaceutical preparation containing gabapentin |
| 07/07/2009 | USRE40838 modulators of opioid receptors; irritable bowel syndrome, drug addiction, including alcohol addiction, depression, anxiety, schizophrenia, eating disorders |
| 07/07/2009 | US7557222 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors Xa and VIIa for the treatment of thrombosis |
| 07/07/2009 | US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 07/07/2009 | US7557113 5-{2-[(t-butoxy)carbonylamino]ethyl}-6-{3-chloro(2-thienyl)}-4-oxo-3-hydr- opyrrolo[3,2-d]pyrimidin-7-carboxyamide; GSK-3 inhibitor; diabetes, diabetic complications, Alzheimer's, neurodegenerative, manic depression, traumatic cerebrospinal injury, alopecia, inflammatory diseases, cancer, immunodeficienc |
| 07/07/2009 | US7557109 Eltoprazine; |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7557089 Use of derivatives of succinate esters for the treatment of dementia |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | CA2523261C Fused pyrimidine derivatives with crf activity |
| 07/07/2009 | CA2490002C Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2461510C Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2425876C Piperidine derivatives as antagonists of tachykinins |